moa glp 1 agonist Mechanisms of action of GLP-1RA Understanding GLP-1 Agonists
Description
Aaboe K., Akram S., Deacon C
Glucagon-like peptide-1: a multi-faceted antiinflammatory agent
Lixisenatide therapy in older patients with type 2 diabetes inadequately controlled on their current antidiabetic treatment: the getgoal-o randomized trial
JAMA Netw Open 2025;8:e2457349.ArticlePubMedPMC 116
The responsible message: Substantial weight loss usually includes some loss of lean tissue
Its important to distinguish between normal initial digestive adjustment and true gastroparesis, which typically involves persistent or worsening symptoms
